Pharmaceutical Executive, Jul 1, 2008 - Pharmaceutical Executive

ADVERTISEMENT

Pharmaceutical Executive, Jul 1, 2008
Features
Pharma's Day in Court
A look at some of the court cases that could actually change the pharma playing field
RNA Revolutionaries
By Walter Armstrong
Could gene silencing be the next great innovation in drug development? Some biotechs are betting on it.
Connect the Dots
By Joe Slota, Deloitte Consulting , Matthew Humphreys, Deloitte Consulting
New technologies and new regulations aim to make pharma's supply chain more secure.
Columns
Get Ready for Your Premiere at Ad Comm
By Laura M. Liotta, Sam Brown
Make your Ad Comm meeting the performance of a lifetime
Tough Nut to Crack
By Tom McDonnell, Vyvanse Marketing , Robert Bedford, InfoMedics
An innovative approach bridges the pediatric communication gap
Exercising your Brand
By Jonathan Richman, Bridge Worldwide
A strict marketing regimen will help keep your brand healthy in the digital
Washington Report
Smooth Sailing for Orphans
By Jill Wechsler
Rare disease treatments are riding high as patient adcovates, pharma companies, and government officials celebrate the ODA's 25th anniversary
Back Page
That Thing about RNA
By Walter Armstrong
No, it's not as glamorous as its double-helixed offspring. But recent revelations about RNA turn even cold-eyed scientists into lyrical romantics
Thought Leader
The Total Customer Experience
By Peter Carlin
Genentech had previously been number one by a very wide margin. This year, that margin started to narrow. Novartis is now a much closer second
Leadership
Get Over It!
By Sander Flaum, Flaum Partners
Rejection is tough to take, but leaders have the drive and ability to bounce back from a setback with boundless energy
From the Editor
Healthcare Funhouse
By Patrick Clinton
It's not that I disagree with the Obama and McCain healthcare proposals. It's that there's nothing actually there to disagree with

ADVERTISEMENT

Click here